Gastrointestinal obstruction in neonates and infants - a four-year profile in Chris Hani Baragwanath Academic

O Baratedi1, J Scribante1,2, A Withers3

  • 1Department of Paediatric Surgery, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, South Africa.

Insights

Gastrointestinal obstruction in South African infants is primarily caused by congenital malformations, not acquired conditions. Sepsis significantly increases postoperative morbidity and mortality in these young patients.

Area of Science:

  • Pediatric Surgery
  • Neonatal Medicine
  • Gastroenterology

Background:

  • Gastrointestinal (GI) obstruction in neonates and infants is a critical condition.
  • Limited data exists on the specific profile of GI obstruction in South African infants.
  • This study addresses the knowledge gap by analyzing cases at Chris Hani Baragwanath Academic Hospital (CHBAH).

Purpose of the Study:

  • To describe the epidemiological and etiological profile of gastrointestinal obstruction in neonates and infants.
  • To identify common causes, management strategies, and outcomes of GI obstruction in this population.
  • To highlight the impact of sepsis on morbidity and mortality.

Main Methods:

  • Retrospective record review of all patients under one year of age with GI obstruction admitted to CHBAH from January 2016 to December 2019.
  • Data collection included demographics, clinical presentation, etiology, diagnostic methods, treatment, complications, and mortality.
  • Analysis focused on comparing congenital versus acquired causes and identifying factors associated with adverse outcomes.

Main Results:

  • A total of 299 patients were included, predominantly male neonates.
  • Congenital malformations (67.89%) were more frequent than acquired conditions (32.11%).
  • Anorectal malformation and small bowel atresia were common congenital causes; intussusception was the most frequent acquired cause. Morbidity was 31.77% and mortality was 5.35%, with sepsis being a major contributing factor.

Conclusions:

  • Congenital anomalies are the leading cause of GI obstruction in neonates and infants in this South African cohort.
  • Postoperative sepsis is a significant driver of morbidity and mortality.
  • Effective management strategies should address both the underlying pathology and the prevention/treatment of sepsis.
Abstract

Related Concept Videos

Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pyloric Obstruction01:11

Pyloric Obstruction

Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...
Intestinal Obstruction I: Introduction01:29

Intestinal Obstruction I: Introduction

Intestinal obstruction is a partial or complete blockage of the small or large intestine that disrupts the normal flow of intestinal contents through the lumen. This interruption impairs digestion, absorption, and fluid balance, and may lead to serious complications if not treated promptly.Mechanical ObstructionMechanical obstruction occurs when a physical blockage prevents intestinal contents from passing, arising from within the lumen or the bowel wall, or from external compression.Adhesions,...
Intestinal Obstruction II: Pathophysiology01:07

Intestinal Obstruction II: Pathophysiology

Intestinal obstruction triggers a series of physiological responses, starting with gas and fluid accumulation in the bowel segment proximal to the obstruction, leading to distension. This distended intestine compresses the diaphragm, hindering lung expansion and potentially leading to reduced respiratory effort, atelectasis, and pneumonia.To overcome the blockage, the gut intensifies contractions, causing colicky abdominal pain, nausea, and vomiting, which reduces fluid and food intake and...